Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07646483
Clinical Trial to Evaluate the Efficacy and Safety of Conjuran® After First and Second Cycle (Repeat) Administration in Patients With Knee OsteoarthritisPharmaResearch Co.,LtdNot Yet RecruitingNot Applicable
NCT07646483Not Yet Recruiting
Not Applicable
Clinical Trial to Evaluate the Efficacy and Safety of Conjuran® After First and...PharmaResearch Co.,Ltd
NCT07646353
First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy AdultsGlaxoSmithKlineNot Yet RecruitingPhase 1
NCT07646353Not Yet Recruiting
Phase 1
First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in H...GlaxoSmithKline
NCT07643766
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic DermatitisEnveda TherapeuticsNot Yet RecruitingPhase 2
NCT07643766Not Yet Recruiting
Phase 2
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in...Enveda Therapeutics
NCT07644546
Immunogenicity of MF59-adjuvanted Versus High-dose Influenza Vaccine in People With HIV: a Randomized Clinical TrialNational Taiwan University HospitalNot Yet RecruitingNot Applicable
NCT07644546Not Yet Recruiting
Not Applicable
Immunogenicity of MF59-adjuvanted Versus High-dose Influenza Vaccine in People W...National Taiwan Universit...
NCT07645794
Clinical Study on a New Diagnostic Strategy for Osteoporosis and Sarcopenia in Chronic Kidney Disease Patients Based on MRI-FFCapital Medical UniversityNot Yet Recruiting
NCT07645794Not Yet Recruiting
—
Clinical Study on a New Diagnostic Strategy for Osteoporosis and Sarcopenia in C...Capital Medical Universit...
NCT07645287
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1Gilead SciencesNot Yet RecruitingPhase 2
NCT07645287Not Yet Recruiting
Phase 2
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologica...Gilead Sciences
NCT07644130
Bergen Four-Day Treatment (B4DT) for Obsessive-Compulsive DisorderTampere UniversityNot Yet RecruitingNot Applicable
NCT07644130Not Yet Recruiting
Not Applicable
Bergen Four-Day Treatment (B4DT) for Obsessive-Compulsive DisorderTampere University
NCT07644728
Sleep Quality and Biomarkers in Adolescent Girls With Anorexia NervosaUniversity Hospital of SplitNot Yet Recruiting
NCT07644728Not Yet Recruiting
—
Sleep Quality and Biomarkers in Adolescent Girls With Anorexia NervosaUniversity Hospital of Sp...
NCT07644507
Role of Intraoperative Computed Tomography in Assessment of Spine Instability in Lumbar Degenerative Disease4th Military Clinical Hospital with Polyclinic, PolandNot Yet Recruiting
NCT07644507Not Yet Recruiting
—
Role of Intraoperative Computed Tomography in Assessment of Spine Instability in...4th Military Clinical Hos...
NCT07644975
Electrolytic Surface Decontamination in the Surgical Treatment of Peri-implantitis: A Randomized Clinical TrialIstanbul UniversityNot Yet RecruitingNot Applicable
NCT07644975Not Yet Recruiting
Not Applicable
Electrolytic Surface Decontamination in the Surgical Treatment of Peri-implantit...Istanbul University
NCT07646015
Validate Smart Breath Analyzer as Screening Tool for Diabetic, Hepatic, Renal, Lung, and Other Metabolic DisordersJSS Medical College HospitalCompleted
NCT07646015Completed
—
Validate Smart Breath Analyzer as Screening Tool for Diabetic, Hepatic, Renal, L...JSS Medical College Hospi...
NCT07646288
Acute Effects of Visual Feedback-Assisted Inspiratory Muscle Training After LobectomyHacettepe UniversityRecruitingNot Applicable
NCT07646288Recruiting
Not Applicable
Acute Effects of Visual Feedback-Assisted Inspiratory Muscle Training After Lobe...Hacettepe University
NCT07645742
Pilot Study of Intermittent Fasting With Immune Checkpoint InhibitorsWest Virginia UniversityNot Yet RecruitingNot Applicable
NCT07645742Not Yet Recruiting
Not Applicable
Pilot Study of Intermittent Fasting With Immune Checkpoint InhibitorsWest Virginia University
NCT07646470
Effects of Chronic Non-invasive Vagus Nerve Stimulation in an Asplenic Individual Suffering From Rheumatoid ArthritisOsteoflow Health ClinicCompletedNot Applicable
NCT07646470Completed
Not Applicable
Effects of Chronic Non-invasive Vagus Nerve Stimulation in an Asplenic Individua...Osteoflow Health Clinic
NCT07645664
Scar Management Through Serial CastingCentre hospitalier de l'Université de Montréal (CHUM)Not Yet RecruitingNot Applicable
NCT07645664Not Yet Recruiting
Not Applicable
Scar Management Through Serial CastingCentre hospitalier de l'U...
NCT07643935
Prognostic Value of 177Lutetium-PSMA Single Photon Emission Tomography and Timing of ResponseCentral Hospital, Nancy, FranceNot Yet Recruiting
NCT07643935Not Yet Recruiting
—
Prognostic Value of 177Lutetium-PSMA Single Photon Emission Tomography and Timin...Central Hospital, Nancy,...
NCT07645339
Efficacy and Safety of a Topical Botanical Extract Formulation for Skin Barrier RepairL'OrealActive Not RecruitingNot Applicable
NCT07645339Active Not Recruiting
Not Applicable
Efficacy and Safety of a Topical Botanical Extract Formulation for Skin Barrier...L'Oreal
NCT07644039
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced MalignanciesPharmaMarRecruitingPhase 1
NCT07644039Recruiting
Phase 1
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advan...PharmaMar
NCT07646561
Transcranial Doppler in Preeclampsia and Its Complications.University Tunis El ManarCompleted
NCT07646561Completed
—
Transcranial Doppler in Preeclampsia and Its Complications.University Tunis El Manar
NCT07645924
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of MigraineKallyope Inc.Not Yet RecruitingPhase 3
NCT07645924Not Yet Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute T...Kallyope Inc.
Result Breakdown
Not yet recruiting14 (70%)
Completed3 (15%)
Recruiting2 (10%)
Active, not recruiting1 (5%)
not_applicable9 (45%)
Not Specified6 (30%)
Phase 12 (10%)
Phase 22 (10%)
Phase 31 (5%)